VALIDATION STUDY
Add like
Add dislike
Add to saved papers

Low plasma D-dimer concentration predicts the absence of traumatic brain injury in children.

BACKGROUND: Head Computerized Tomography (CT) has significant risks, especially in children. To reduce this burden, we sought to develop a biomarker panel that predicts the absence of traumatic brain injury (TBI) on head CT.

METHODS: We conducted a prospective cohort observational study followed by validation in a retrospective cohort at a regional pediatric trauma center. The prospective cohort included 57 consecutive children evaluated for TBI in the emergency department between September 2007 and March 2008. At the time of initial evaluation, blood was obtained to measure electrolytes, coagulation markers, complete blood count, and plasma levels of s100beta, D-dimer, and matrix metalloproteinase-9. We conducted routine statistical analysis to determine which predicted TBI on head CT. The independent retrospective cohort included 57 consecutive patients evaluated for the same indication.

RESULTS: All patients generally met common clinical criteria (such as the CHALICE criteria 4) for head CT after trauma. Plasma levels of D-dimer were associated with TBI on head CT by univariate analysis (p < 0.001). Other markers including prothrombin time, partial thromboplastin time, and s100beta were not. D-dimer also had the strongest association in multivariate analysis (p = 0.02). This association was independent of and stronger than the baseline Glascow Coma Scale (p = 0.08). A D-dimer level cut-off of 500 pg/microl had 94% negative predictive value (p < 0.001) for brain injury on head CT. The discriminatory capacity of this D-dimer level was confirmed in the independent retrospective cohort.

CONCLUSIONS: In children who meet clinical criteria for a head CT scan after trauma, low plasma d-dimer suggests the absence of significant brain injury.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app